Hepatitis C Coinfection Enhances Sensitization of CD4 + T-Cells Towards Fas-Induced Apoptosis in Viraemic and Haart-Controlled HIV-1-Positive Patients

Abstract

Background

Recently, we identified increased rates of CD4⁺ T-cell apoptosis in HCV-infected HIV-positive patients as a potential mechanism for enhanced mortality in patients with HIV/HCV coinfection. Since this effect might be attributed to changes in receptor-induced apoptosis, we studied expression and function of Fas ligand (FasL) and its death receptor Fas on CD4⁺ T-cells in HIV/HCV coinfection.

Methods

In this cross-sectional study, we simultaneously analysed surface expression of Fas and FasL on CD4⁺ T-cells and serum levels of soluble FasL in HCV/HIV-coinfected, HIV-monoinfected and HCV-monoinfected patients. Susceptibility to FasL-induced apoptosis was analysed by incubating isolated peripheral blood mono-nuclear cells with rhFasL followed by measuring CD4⁺ T-cell apoptosis.

Results

HIV and HCV monoinfection were associated with significantly enhanced surface expression of Fas. Highest Fas expression was detected in HIV/HCV-coinfected patients and correlated with low CD4⁺ T-cell counts. By contrast, elevated levels of soluble and cellular FasL were found only in patients with HIV infection, but not in patients with HCV infection. Importantly, enhanced Fas expression in HCV/HIV coinfection rendered CD4⁺ T-cells more susceptible towards FasL-induced apoptosis. While effective HAART normalized expression and secretion of FasL in HIV-infected and HIV/HCV-coinfected patients, expression of Fas decreased only slightly and still remained significantly elevated as compared with healthy controls.

Conclusions

Our findings suggest a synergistic mechanism in HIV/HCV coinfection between up-regulation of Fas expression on CD4⁺ T-cells and HIV-induced elevated levels of cellular and soluble FasL. Together, both effects contribute to enhanced apoptosis of CD4⁺ T-cells in HIV/HCV coinfection.

References

Ameisen

J.C.

, Capron

Cell dysfunction and depletion in AIDS: the programmed celldeath hypothesis. Immunol Today 1991; 12: 102–105.

Krammer

P.H.

CD95's deadly mission in the immune system. Nature 2000; 407: 789–795.

Sun

E.W.

, Shi

Y.F.

Apoptosis: the quiet death silences the immune system. Pharmacol Ther 2001; 92: 135–145.

Hildeman

, Jorgensen

, Kappler

, Marrack

Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 2007; 19: 516–521.

Gougeon

M.L.

T cell apoptosis as a consequence of chronic activation of the immune system in HIV infection. Adv Exp Med Biol 1995; 374: 121–127.

Gougeon

M.L.

, Lecoeur

, Dulioust

Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T-cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156: 3509–3520.

Westendorp

M.O.

, Frank

, Ochsenbauer

Sensitization of T-cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497–500.

Luciani

, Matarrese

, Giammarioli

A.M.

CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95(APO-1/Fas)-mediated apoptosis of human resting CD4(+)T lymphocytes. Cell Death Differ 2004; 11: 574–582.

Poonia

, Pauza

C.D.

, Salvato

M.S.

Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology 2009; 6: 91.

10.

Anderson

K.B.

, Guest

J.L.

, Rimland

Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 2004; 39: 1507–1513.

11.

Greub

, Ledergerber

, Battegay

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356: 1800–1805.

12.

Giordano

T.P.

, Kramer

J.R.

, Souchek

, Richardson

, El-Serag

H.B.

Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004; 164: 2349–2354.

13.

Pineda

J.A.

, Romero-Gómez

, Díaz-García

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41: 779–789.

14.

Kramer

J.R.

, Giordano

T.P.

, Souchek

, El-Serag

H.B.

Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol 2005; 42: 309–314.

15.

El-Serag

H.B.

, Giordano

T.P.

, Kramer

, Richardson

, Souchek

Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol 2005; 3: 175–183.

16.

Martín

J.C.

, Castilla

, López

, Arranz

, González-Lahoz

, Soriano

Impact of chronic hepatitis C on HIV-1 disease progression. HIV Clin Trials 2004; 5: 125–131.

17.

Rockstroh

J.K.

, Mocroft

, Soriano

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192: 992–1002.

18.

Taya

, Torimoto

, Shindo

, Hirai

, Hasebe

, Kohgo

Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br J Haematol 2000; 110: 89–97.

19.

Fischer

, Baumert

, Blum

Hepatitis C virus infection and apoptosis. World J Gastroenterol 2007; 13: 4865–4872.

20.

Körner

, Krämer

, Schulte

Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients. Clin Sci 2009; 116: 861–870.

21.

Dianzani

, Bensi

, Savarino

Role of FAS in HIV infection. Curr HIV Res 2003; 1: 405–417.

22.

Katsikis

P.D.

, Wunderlich

E.S.

, Smith

C.A.

, Herzenberg

L.A.

, Herzenberg

L.A.

Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181: 2029–2036.

23.

Aries

S.P.

, Schaaf

, Müller

, Dennin

R.H.

, Dalhoff

Fas (CD95) expression on CD4+ T-cells from HIV-infected patients increases with disease progression. J Mol Med 1995; 73: 591–593.

24.

Patki

A.H.

, Georges

D.L.

, Lederman

M.M.

CD4+-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects. Clin Diagn Lab Immunol 1997; 4: 736–741.

25.

Mitra

, Steiner

, Lynch

D.H.

, Staiano-Coico

, Laurence

HIV-1 upregulates Fas ligand expression in CD4+ T-cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996; 87: 581–585.

26.

Hosaka

, Oyaizu

, Than

, Pahwa

Correlation of loss of CD4 T-cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants. Clin Immunol 2000; 95: 20–25.

27.

Hosaka

, Oyaizu

, Kaplan

M.H.

, Yagita

, Pahwa

Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons. J Infect Dis 1998; 178: 1030–1039.

28.

Llano

, Barretina

, Gutiérrez

Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001; 75: 10319–10325.

29.

Fluur

, De Milito

, Fry

T.J.

Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J Immunol 2007; 178: 5340–5350.

30.

Nunnari

, Xu

, Acheampong

E.A.

Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection. J Neurovirol 2005; 11: 319–328.

31.

Cianci

, De Luca

, Cammarota

, Cauda

, Pandolf

HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease. Eur Rev Med Pharmacol Sci 2008; 12: 67–69.

32.

Soriano-Sarabia

, Vallejo

, Molina-Pinelo

HIV-hepatitis C virus co-infection is associated with decreased plasmatic IL-7 levels. AIDS 2007; 21: 253–255.

33.

Hayashi

, Mita

Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat 1999; 6: 357–365.

34.

Calabrese

, Pontisso

, Pettenazzo

Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 2000; 31: 1153–1159.

35.

Zignego

A.L.

, Giannini

, Monti

, Gragnani

Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 2007; 39 Suppl 1: S38–S45.

36.

Núñez

, Soriano

, López

Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients. Clin Infect Dis 2006; 43: 1209–1212.

37.

Macías

, Japón

M.A.

, Sáez

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection. J Infect Dis 2005; 192: 1566–1576.

38.

Munshi

, Balasubramanian

, Koziel

, Ganju

R.K.

, Groopman

J.E.

Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 2003; 188: 1192–1204.

39.

Roger

P.M.

, Breittmayer

J.P.

, Arlotto

Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin Exp Immunol 1999; 118: 412–416.

40.

Dieye

T.N.

, Van Vooren

J.P.

, Delforge

M.L.

, Liesnard

, Devleeschouwer

, Farber

C.M.

Spontaneous apoptosis and highly active antiretroviral therapy (HAART). Biomed Pharmacother 2000; 54: 16–20.

41.

Qurishi

, Kreuzberg

, Lüchters

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003; 362: 1708–1713.

42.

Dyrhol-Riise

A.M.

, Stent

, Røsok

B.I.

, Voltersvik

, Olofsson

, Asjö

The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy. Clin Immunol 2001; 101: 169–179.

43.

Herbeuval

J.P.

, Nilsson

, Boasso

HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. AIDS 2009; 23: 35–40.

44.

Caggiari

, Zanussi

, Bortolin

M.T.

Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients. Clin Exp Immunol 2000; 120: 101–106.

45.

Ohnimus

, Heinkelein

, Jassoy

Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1. J Immunol 1997; 159: 5246–5252.

46.

Roggero

, Robert-Hebmann

, Harrington

Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling. J Virol 2001; 75: 7637–7650.